First Affiliated Hospital of Chongqing Medical University Reports Findings in Co lon Cancer (Machine learning application identifies plasma markers for proteinur ia in metastatic colorectal cancer patients treated with Bevacizumab)

扫码查看

Abstract

By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Oncology - Colon Cance r is the subject of a report. According to news reporting originating from Chong qing, People's Republic of China, by NewsRx correspondents, research stated, "Pr oteinuria is a common complication after the application of bevacizumab therapy in patients with metastatic colorectal cancer, and severe proteinuria can lead t o discontinuation of the drug. There is a lack of sophisticated means to predict bevacizumab-induced proteinuria, so the present study aims to predict bevacizum ab-induced proteinuria using peripheral venous blood samples."

Key words

Chongqing/People's Republic of China/A sia/Antineoplastic Monoclonal Antibodies/Antineoplastics/Bevacizumab Therapy/Biomarkers/Blood/Cancer/Colon Cancer/Colorectal Research/Cyborgs/Diagnost ics and Screening/Drugs and Therapies/Emerging Technologies/Gastroenterology/Health and Medicine/Hematology/Immunologic Agents/Machine Learning/Monoclon al Antibodies/Oncology/Pharmaceuticals/Plasma/Risk and Prevention/Tyrosine Kinase Inhibitors/VEGF - VEGFR Inhibitors/VEGFR Inhibitors

引用本文复制引用

出版年

2024

Robotics & Machine Learning Daily News

ISSN：

段落导航